EDITORIALS

CEACAM1: A Marker With a Difference or More of the Same?

Timothy A. Plunkett and Paul A. Ellis

JCO Nov 1 2002: 4273–4275. [Full Text] [PDF]

The Multifunctional, Multi-Institutional, and Sometimes Even Global Phase I Study: A Better Life for Phase I Evaluations or Just "Living Large"?

Anthony W. Tolcher, Chris H. Takimoto, and Eric K. Rowinsky

JCO Nov 1 2002: 4276–4278. [Full Text] [PDF]

ORIGINAL REPORTS
Lung Cancer
	Expression of CEACAM1 in Adenocarcinoma of the Lung: A Factor of Independent Prognostic Significance
	Eckart Laack, Haleh Nikbakht, Anja Peters, Christian Kugler, Yvonne Jasiewicz, Lutz Edler, Jens Brümmer, Udo Schumacher, and Dieter Kurt Hossfeld
	JCO Nov 1 2002: 4279–4284. [Abstract] [Full Text] [PDF]
	Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer
	G.V. Scagliotti, F. De Marinis, M. Rinaldi, L. Crinò, C. Gridelli, S. Ricci, E. Matano, C. Boni, M. Marangolo, G. Failla, G. Altavilla, V. Adamo, A. Ceribelli, M. Clerici, F. Di Costanzo, L. Frontini, and M. Tonato
	JCO Nov 1 2002: 4285–4291. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types
	J. Baselga, D. Rischin, M. Ranson, H. Calvert, E. Raymond, D.G. Kieback, S.B. Kaye, L. Gianni, A. Harris, T. Bjork, S.D. Averbuch, A. Feyereislova, H. Swaisland, F. Rojo, and J. Albanell
	JCO Nov 1 2002: 4292–4302. [Abstract] [Full Text] [PDF]
	Dosage Adjustment and Pharmacokinetic Profile of Irinotecan in Cancer Patients With Hepatic Dysfunction
	Eric Raymond, Valérie Boige, Sandrine Faivre, Ger-Jan Sanderink, Olivier Rixe, Laurent Vernillet, Christian Jacques, Michel Gatineau, Michel Ducreux, and Jean-Pierre Armand
	JCO Nov 1 2002: 4303–4312. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Randomized Trial of Influenza Vaccine With Granulocyte-Macrophage Colony-Stimulating Factor or Placebo in Cancer Patients
	Ramesh K. Ramanathan, Douglas M. Potter, Chandra P. Belani, Samuel A. Jacobs, Stefan Gravenstein, Felix Lim, Hyoung Kim, Steven Savona, Terry Evans, Dianne Buchbarker, Mary B. Simon, Jane K. Depee, and Donald L. Trump
	JCO Nov 1 2002: 4313–4318. [Abstract] [Full Text] [PDF]
	The Case Identification Challenge in Measuring Quality of Cancer Care
	Marjorie L. Pearson, Patricia A. Ganz, Kimberly McGuigan, Jennifer R. Malin, John Adams, and Katherine L. Kahn
	JCO Nov 1 2002: 4353–4360. [Abstract] [Full Text] [PDF]
	Pain and Quality of Life After Treatment in Patients With Locally Recurrent Rectal Cancer
	Nestor F. Esnaola, Scott B. Cantor, Margo L. Johnson, Attiqa N. Mirza, Alexander R. Miller, Steven A. Curley, Christopher H. Crane, Charles S. Cleeland, Nora A. Janjan, and John M. Skibber
	JCO Nov 1 2002: 4361–4367. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
	S. Vincent Rajkumar, Suzanne Hayman, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Philip R. Greipp, Susan Geyer, Nancy Iturria, Rafael Fonseca, John A. Lust, Robert A. Kyle, and Thomas E. Witzig
	JCO Nov 1 2002: 4319–4323. [Abstract] [Full Text] [PDF]
	Relevance of Bone Marrow Cell Dose on Allogeneic Transplantation Outcomes for Patients With Acute Myeloid Leukemia in First Complete Remission: Results of a European Survey
	Vanderson Rocha, Myriam Labopin, Eliane Gluckman, Ray Powles, William Arcese, Andrea Bacigalupo, Josy Reiffers, Arturo Iriondo, Olle Ringdén, Tapani Ruutu, and Francesco Frassoni
	JCO Nov 1 2002: 4324–4330. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Low Sensitivity of the ki-ras Polymerase Chain Reaction for Diagnosing Pancreatic Cancer From Pancreatic Juice and Bile: A Multicenter Prospective Trial
	Lorenz Trümper, Markus Menges, Heiner Daus, Daniel Köhler, Jan-Olaf Reinhard, Michael Sackmann, Cornelius Moser, Alexandra Sek, Georg Jacobs, Martin Zeitz, and Michael Pfreundschuh
	JCO Nov 1 2002: 4331–4337. [Abstract] [Full Text] [PDF]
	Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters
	Martin R. Weihrauch, Edmund Skibowski, Thomas C. Koslowsky, Wilfried Voiss, Daniel Re, Ferdinand Kuhn-Regnier, Carolin Bannwarth, Michel Siedek, Volker Diehl, and Heribert Bohlen
	JCO Nov 1 2002: 4338–4343. [Abstract] [Full Text] [PDF]

Sarcomas
	Primary Adult Soft Tissue Sarcoma: Time-Dependent Influence of Prognostic Variables
	Alexander Stojadinovic, Denis H.Y. Leung, Peter Allen, Jonathan J. Lewis, David P. Jaques, and Murray F. Brennan
	JCO Nov 1 2002: 4344–4352. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
	Harold F. Dvorak
	JCO Nov 1 2002: 4368–4380. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Quality of Breast Cancer Care: What Do We Know?
	Jennifer L. Malin, Mark A. Schuster, Katherine A. Kahn, and Robert H. Brook
	JCO Nov 1 2002: 4381–4393. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Sites of Involvement in Non-Hodgkin’s Lymphoma: Case 1. Isolated Orbit Relapse After Allogeneic Bone Marrow Transplantation for Malignant Lymphoma

Charmaine Hon, Wing Y. Au, Edmond S.K. Ma, Alvin K.H. Kwok, Albert K.W. Lie, and Raymond H.S. Liang

JCO Nov 1 2002: 4394–4395. [Full Text] [PDF]

Unusual Sites of Involvement in Non-Hodgkin's Lymphoma: Case 2. Isolated Meningeal Anaplastic Large-Cell Lymphoma

S. Aloulou, J. Bosq, D. Vanel, and V. Ribrag

JCO Nov 1 2002: 4395–4397. [Full Text] [PDF]

Unusual Sites of Involvement in Non-Hodgkin's Lymphoma: Case 3. Intussusception as a Rare Complication of Mantle-Cell Lymphoma

C. Sucker, K.-M. Klima, G. Doelken, C.-D. Heidecke, G. Lorenz, and M. Stockschlaeder

JCO Nov 1 2002: 4397–4398. [Full Text] [PDF]

ART OF ONCOLOGY

Parents With Cancer: Who’s Looking After the Children?

Paula K. Rauch, Anna C. Muriel, and Ned H. Cassem

JCO Nov 1 2002: 4399–4402. [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

Increased Risk of Malignant Mullerian Tumor of the Uterus Among Women With Breast Cancer Treated by Tamoxifen

C. Bouchardy, H.M. Verkooijen, G. Fioretta, A.P. Sappino, and G. Vlastos

JCO Nov 1 2002: 4403. [Full Text] [PDF]

Revisiting Truth and Consequences: What to Do When the Patient Doesn’t Want to Know

Mellar P. Davis and Robert Dreicer

JCO Nov 1 2002: 4403-a–4404. [Full Text] [PDF]

Nail Toxicity Related to Weekly Taxanes: An Important Issue Requiring a Change in Common Toxicity Criteria Grading?

Simon Spazzapan, Diana Crivellari, Davide Lombardi, Cristina Scuderi, Maria Donatella Magri, Andrea Veronesi, Alessandro Gatti, and Edith A. Perez

JCO Nov 1 2002: 4404–4405. [Full Text] [PDF]

Very-Long-Term Survival Rates of Patients With Cancer

Hermann Brenner and Timo Hakulinen

JCO Nov 1 2002: 4405–4409. [Full Text] [PDF]

ERRATA

ERRATUM

JCO Nov 1 2002: 4409. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.